HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Si-Ping Hu Selected Research

QX-222 (QX 222)

1/2014Coapplication of lidocaine and membrane-impermeable lidocaine derivative QX-222 produces divergent effects on evoked and spontaneous nociceptive behaviors in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Si-Ping Hu Research Topics

Disease

1Memory Disorders (Memory Loss)
11/2017
1Postoperative Pain
11/2017
1Pain (Aches)
01/2014
1Hyperalgesia
01/2014
1Acute Pain
01/2014
1Fatty Liver
10/2012
1Non-alcoholic Fatty Liver Disease
03/2011

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
10/2012 - 03/2011
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
11/2017
1Thalidomide (Thalomid)FDA Link
11/2017
1Lidocaine (Xylocaine)FDA LinkGeneric
01/2014
1QX-222 (QX 222)IBA
01/2014
1Analgesics (Analgesic Drugs)IBA
01/2014
1Formaldehyde (Formol)FDA Link
01/2014
1Freund's AdjuvantIBA
01/2014
1JNK Mitogen-Activated Protein KinasesIBA
10/2012
1Uncoupling Protein 2IBA
03/2011
1Messenger RNA (mRNA)IBA
03/2011
1Therapeutic UsesIBA
03/2011
1BerberineIBA
03/2011

Therapy/Procedure

1Nerve Block (Nerve Blocks)
01/2014